Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

Tobolowsky, Farrell A.; Nsubuga, Fred; Gilani, Zunera; Kisakye, Annet; Ndagije, Helen; Kyabayinze, Daniel; Gidudu, Jane F.

doi:10.3201/eid3004.231361

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

4 2024
By Tobolowsky, Farrell A. ; Nsubuga, Fred ; Gilani, Zunera ; ...
http://dx.doi.org/10.3201/eid3004.231361
Source: Emerg Infect Dis. 2024; 30(4):775-778

[PDF-400.32 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

Tobolowsky, Farrell A. ; Nsubuga, Fred ; Gilani, Zunera ; Kisakye, Annet ; Ndagije, Helen ; ... More +

Tobolowsky, Farrell A. ; Nsubuga, Fred ; Gilani, Zunera ; Kisakye, Annet ; Ndagije, Helen ; Kyabayinze, Daniel ; Gidudu, Jane F. Less -
Description:

Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.
Subjects:

[+]

Immunization Poliovirus Poliovirus Vaccine, Oral Vaccination
Keywords:

[+]

Bacteria Burkholderia Pseudomallei History Melioidosis Poliovirus Uganda Vaccines Vaccine Safety Viruses
Source:

Emerg Infect Dis. 2024; 30(4):775-778
Pubmed ID:

38526214
Pubmed Central ID:

PMC10977820
Document Type:

Journal Article
Genre:

Dispatch
Place as Subject:

Uganda
Volume:

30
Issue:

4
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:2f94cb2b412c6e7f6c538607cceb570333a985b4007f593a58354a90fd7f6888
Download URL:

https://stacks.cdc.gov/view/cdc/152962/cdc_152962_DS1.pdf
File Type:

	23-1361-F.gif	gif
	23-1361-F.jpg	jpeg
	23-1361.nxml	xml

More +